🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 20% of ingredients have research evidence
B Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

2 Capsule(s) Serving Size
60 Servings
Other Combinations Product Type
20% Evidence Coverage

Supplement Facts — Evidence Check

Chromax
200 mcg (167% DV)
📊 Market median: 500.0mg (234 products) 📚 95 studies (Tier A: 0, B: 35)
This product: 750mg
Banaba Leaf Extract
100 mg
📊 Market median: 200.0mg (198 products) 📚 6 studies — no high-quality reviews
This product: 50mg
Gymnema Leaf Extract
100 mg

Other Ingredients

Cellulose Magnesium Stearate Silicon Dioxide

Label Claims — Verification

All Other
Structure/Function
All Other (98% of products) Structure/Function (87% of products) Nutrient (16% of products)

Target Groups

Adult (18 - 50 Years) Women (not pregnant or lactating)

Product Information

📋 Directions for Use

Directions for use: As a dietary supplement- Training days: Consume 1 serving with your post-workout carb-containing shake or meal, and 1 serving with any other high-carb meal of the day. Non-Training Days: Consume 1 serving with each of 2 high-carb meals.

⚠️ Warnings & Precautions

Warning: Read entire label prior to use. Discontinue use and call a physician or licensed qualified health care professional immediately if adverse reactions occur. Do not exceed recommended serving.

Not for use by individuals under the age of 18. Keep out of reach of children.

Do not use if you are pregnant or nursing. Consult your physician prior to use if you are using any medications and/or have any medical conditions.

🧪 Formulation Notes

MTS Nutrition Nutrient Driver is the ultimate glucose disposal agent. It works to help Drive nutrients into your muscles, prevent fat storage, and prevent negative health issues caused by fluctuations in blood sugar. If that wasn't enough, check out all the other health benefits of taking Nutrient Driver! Supports glucose metabolism Helps regulate insulin release Decreased food cravings Potent water and fat-soluble antioxidant Increased system support Brain health support

FDA Inspected Facility Made in a GMP Facility 100% Satisfaction Guarantee Glucose disposal agent 25% Hunger reduction 26% Decrease in fasting insulin

50mg r-ALA

Product Details

UPC / SKU 8 55590 00638 9
DSLD Entry Date 2025-02-23
Product Type Other Combinations
Form Capsule
DSLD ID 323116
Data Updated 2026-04-11

Research Evidence

21 Research Sources
52 Avg Quality Score
13 Rct
4 Meta Analysis
2 Systematic Review
2 Clinical Trial
A Alpha-lipoic acid for diabetic peripheral neuropathy
Systematic Review The Cochrane database of systematic reviews 2024
B Efficacy and Safety of the Combination of Palmitoylethanolamide, Superoxide Dismutase, Alpha Lipoic Acid, Vitamins B12, B1, B6, E, Mg, Zn and Nicotinamide for 6 Months in People with Diabetic Neuropathy
Rct Nutrients 2024
B Alpha Lipoic Acid Supplementation and Iron Homeostasis: A Comprehensive Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials
Meta Analysis International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition 2024
B Effectiveness of alpha-lipoic acid in patients with neuropathic pain associated with type I and type II diabetes mellitus: A systematic review and meta-analysis
Meta Analysis Medicine 2023
C The effects of alpha-lipoic acid supplementation on glucose control and lipid profiles among patients with metabolic diseases: A systematic review and meta-analysis of randomized controlled trials
Meta Analysis Metabolism: clinical and experimental 2018
C A systematic review and meta-analysis of α-lipoic acid in the treatment of diabetic peripheral neuropathy
Meta Analysis European journal of endocrinology 2012
C Oral Alpha Lipoic Acid Treatment for Symptomatic Diabetic Peripheral Neuropathy: A Randomized Double-Blinded Placebo-Controlled Study
Rct Endocrine, metabolic & immune disorders drug targets 2020
C A randomized, double-blind, placebo controlled study to evaluate the effect of alpha-lipoic acid on inhibition of ADP-and collagen-induced platelet aggregation ex vivo in diabetic neuropathy patients on gabapentin or pregabalin
Rct Journal of postgraduate medicine 2024
C Ranking Alpha Lipoic Acid and Gamma Linolenic Acid in Terms of Efficacy and Safety in the Management of Adults With Diabetic Peripheral Neuropathy: A Systematic Review and Network Meta-analysis
Systematic Review Canadian journal of diabetes 2024
C Effect analysis of tanshinone IIA sulfonate sodium combined with a-lipoic acid in patients with diabetes peripheral neuropathy.
Rct Pakistan journal of pharmaceutical sciences
View all evidence for Alpha Lipoic Acid →

Compare Similar Products

View all Alpha Lipoic Acid products →